Dispersões sólidas e complexos de inclusão como estratégia para o incremento da solubilidade de amiodarona

Detalhes bibliográficos
Autor(a) principal: Rubim, Alexandre Machado
Data de Publicação: 2016
Tipo de documento: Tese
Idioma: por
Título da fonte: Manancial - Repositório Digital da UFSM
Texto Completo: http://repositorio.ufsm.br/handle/1/17958
Resumo: This study aimed to develop solid dispersions (SD) and inclusion complex (IC) using as carriers hydrophilic polymers (polyethylene glycol PEGs 1500, 4000 and 6000) and cyclodextrins (CDs) (β–cyclodextrin, metil-β-cyclodextrin and hydroxypropy-β-cyclodextrin), respectively, in order to verify the influence of each technological approach in the solubility of Amiodarone Hydrochloride (AMH). SD was prepared in the proportion AMH:PEGs of 1:1 and 1:10 (w/w) by the fusion and kneading techniques. IC were prepared by co-evaporation, freeze-drying and spray-drying methods, and the proportion AMD: CD of 1:1 (w/w) was used. For both approaches, AL-type solubility diagrams and thermodynamic approaches favorable to the formation of this new solid entity were obtained. The AMH solubility in different physiological media (acid buffer pH 1.2, acetate buffer pH 4.5 and phosphate buffer pH 6.8 and water) showed a strong dependence of its ionization due to the presence of amine chemical, which ionizes itself in a greater proportion in more acid means, below the AMH pKA (6.56). In order to characterize SD and CI, different techniques were used, such as X-Ray Diffraction (XRD), Forrier Transform Infrared Spectroscopy (FT-IR), Differential Scanning Calorimetry (DSC), Scanning Electronic Miscroscopy (SEM), Proton Nuclear Magnetic Resonance (RMN), determination of Specific Surface Area of the particles (SBET) and studies about Molecular Modeling (MM), as well as the determination of dissolution profiles between pure AMH and the solid products obtained. From the DRX, FT-IR and DSC analysis, it was possible to verify a strong interaction in a molecular level between AMH and the studied carriers. With the aid of SEM and SSA analysis, it was diagnosed a morphological alteration on the AMH crystals after the IC formation, as well as an increase of the superficial area of the particles in relation to pure AMH. For the determination of each portion of AMH molecule that is inside the cyclodextrin cavity, RMN and MM were used. RMN spectra showed strong evidence that the complexation process with methyl-β-cyclodextrin occurred by the lipophilic side, constituted by a diethylamide group. MM was used from an IC containing AMH and methyl-β-cyclodextrin in order to determine the binding energy, amount of charge transferred and the distances between the principal atoms. According to the results, it was determined a strong interaction between the diethylamide group of AMH with the methyl-β-cyclodextrin cavity, compounding a stable complex with the binding energy of 0.76 eV, confirming the results found by RMN. The obtained dissolution profiles showed to suffer a great influence of SD and CI, as well as the preparation methods of these products. It was also developed three formulations for the obtainment of immediate release tablets containing 10 mg de AMH complex with methyl-β-cyclodextrin by direct compression. The batches were submitted to tests of quality control, and the formulation 1 presented friability superior to 1.5%, which rendered this formulation improper for the execution of dissolution profiles and continuation of the studies. The tablets obtained from the F2 and F3 formulations presented satisfactory results in relation to the tests of variation of weigh, hardness, friability, disintegration time and AMH content. These two formulations were selected for the execution of dissolution profiles using water and acetate buffer pH 4.5. For both evaluated mediums, there was an increase in the dissolved amount of AMH from the tablets in relation to the pure AMH, demonstrating that IC can be useful strategies in the pharmacotechnical developments of new solid oral pharmaceutical ways.
id UFSM_49170199de3790e04f1629090230a3e1
oai_identifier_str oai:repositorio.ufsm.br:1/17958
network_acronym_str UFSM
network_name_str Manancial - Repositório Digital da UFSM
repository_id_str
spelling Dispersões sólidas e complexos de inclusão como estratégia para o incremento da solubilidade de amiodaronaSolid dispersion and inclusion complex as strategy for the enhancement of amiodarone solubilityDispersão sólidaComplexo de inclusãoComprimidosPerfil de dissoluçãoCloridrato de amiodaronaSolid dispersionInclusion complexTabletsDissolution profileAmiodarone hydrochlorideCNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIAThis study aimed to develop solid dispersions (SD) and inclusion complex (IC) using as carriers hydrophilic polymers (polyethylene glycol PEGs 1500, 4000 and 6000) and cyclodextrins (CDs) (β–cyclodextrin, metil-β-cyclodextrin and hydroxypropy-β-cyclodextrin), respectively, in order to verify the influence of each technological approach in the solubility of Amiodarone Hydrochloride (AMH). SD was prepared in the proportion AMH:PEGs of 1:1 and 1:10 (w/w) by the fusion and kneading techniques. IC were prepared by co-evaporation, freeze-drying and spray-drying methods, and the proportion AMD: CD of 1:1 (w/w) was used. For both approaches, AL-type solubility diagrams and thermodynamic approaches favorable to the formation of this new solid entity were obtained. The AMH solubility in different physiological media (acid buffer pH 1.2, acetate buffer pH 4.5 and phosphate buffer pH 6.8 and water) showed a strong dependence of its ionization due to the presence of amine chemical, which ionizes itself in a greater proportion in more acid means, below the AMH pKA (6.56). In order to characterize SD and CI, different techniques were used, such as X-Ray Diffraction (XRD), Forrier Transform Infrared Spectroscopy (FT-IR), Differential Scanning Calorimetry (DSC), Scanning Electronic Miscroscopy (SEM), Proton Nuclear Magnetic Resonance (RMN), determination of Specific Surface Area of the particles (SBET) and studies about Molecular Modeling (MM), as well as the determination of dissolution profiles between pure AMH and the solid products obtained. From the DRX, FT-IR and DSC analysis, it was possible to verify a strong interaction in a molecular level between AMH and the studied carriers. With the aid of SEM and SSA analysis, it was diagnosed a morphological alteration on the AMH crystals after the IC formation, as well as an increase of the superficial area of the particles in relation to pure AMH. For the determination of each portion of AMH molecule that is inside the cyclodextrin cavity, RMN and MM were used. RMN spectra showed strong evidence that the complexation process with methyl-β-cyclodextrin occurred by the lipophilic side, constituted by a diethylamide group. MM was used from an IC containing AMH and methyl-β-cyclodextrin in order to determine the binding energy, amount of charge transferred and the distances between the principal atoms. According to the results, it was determined a strong interaction between the diethylamide group of AMH with the methyl-β-cyclodextrin cavity, compounding a stable complex with the binding energy of 0.76 eV, confirming the results found by RMN. The obtained dissolution profiles showed to suffer a great influence of SD and CI, as well as the preparation methods of these products. It was also developed three formulations for the obtainment of immediate release tablets containing 10 mg de AMH complex with methyl-β-cyclodextrin by direct compression. The batches were submitted to tests of quality control, and the formulation 1 presented friability superior to 1.5%, which rendered this formulation improper for the execution of dissolution profiles and continuation of the studies. The tablets obtained from the F2 and F3 formulations presented satisfactory results in relation to the tests of variation of weigh, hardness, friability, disintegration time and AMH content. These two formulations were selected for the execution of dissolution profiles using water and acetate buffer pH 4.5. For both evaluated mediums, there was an increase in the dissolved amount of AMH from the tablets in relation to the pure AMH, demonstrating that IC can be useful strategies in the pharmacotechnical developments of new solid oral pharmaceutical ways.O presente estudo teve como objetivo desenvolver dispersões sólidas (DS) e complexos de inclusão (CI) utilizando como carreadores os polímeros hidrofílicos (polietilenoglicois PEGs 1500, 4000 e 6000) e ciclodextrinas (CDs) (β-ciclodextrina, metil-β-ciclodextrina e hidroxipropil-β-ciclodextrina) respectivamente, com a finalidade de verificar a influência de cada abordagem tecnológica na solubilidade do Cloridrato de Amiodarona (AMH). DS foram preparadas nas proporções AMH:PEGs de 1:1 e 1:10 (p/p) pelos métodos de fusão e amassamento. Os CI foram preparados pelos métodos de coevaporação, freeze-drying e spray-drying utilizando a proporção AMH:CDs de 1:1 (p/p). Para ambas as abordagens, foram obtidos diagramas de solubilidades do tipo AL e propriedades termodinâmicas favoráveis as formações destas novas entidades sólidas. A solubilidade do AMH em diferentes meios fisiológicos (tampão ácido 1,2; tampão acetato pH 4,5; tampão fosfato pH 6,8 e água) demonstrou uma forte dependência da sua ionização devido à presença do grupo químico amina, o qual se ioniza em maior proporção em ambientes mais ácidos, ou seja, abaixo do pKa do AMH (6,56). Com a finalidade de caracterizar as DS e CI foram utilizadas diferentes técnicas como difração de raios-X (DRX), espectroscopia no infravermelho com transformada de Fourier (FT-IR), calorimetria exploratória diferencial (DSC), microscopia eletrônica de varredura (MEV), ressonância magnética nuclear do próton (RMN), determinação da área superficial específica das partículas (ASE), estudos de modelagem molecular (MM), assim como a determinação dos perfis de dissolução entre o AMH puro e os produtos sólidos obtidos. A partir das análises de DRX, FT-IR e DSC foi possível verificar uma forte interação em nível molecular entre o AMH e os carreadores estudados. Com o auxílio das análises de MEV e ASE foi constatada uma alteração morfológica dos cristais do AMH após a formação dos CI, assim como um aumento da área superficial das partículas em relação ao AMH puro. Para a determinação da porção da molécula do AMH que se encontra dentro da cavidade da ciclodextrina, foram utilizadas a RMN e a MM. Os espectros de RMN mostraram um forte indício de que o processo de complexação com a metil-β-ciclodextrina ocorreu pelo lado lipofílico, constituído por um grupo dietilamina. A MM foi realizada a partir do CI contendo AMH e metil-β-ciclodextrina com a finalidade de determinar as energias de ligação, quantidade de carga transferida e as distâncias entre os principais átomos. Conforme os resultados, constatou-se uma forte interação entre o grupo dietilamina do AMH com a cavidade da metil-β-ciclodextrina, formando um complexo estável com energia de ligação de 0,76 eV, confirmando assim os resultados encontrados por RMN. Os perfis de dissolução obtidos demonstraram sofrer grande influência do tipo de DS e CI, assim como dos métodos de preparo destes produtos. Também foram desenvolvidas 3 formulações para obtenção de comprimidos de liberação imediata contendo 10 mg de AMH complexado com metil-β-ciclodextrina por compressão direta. Os lotes foram submetidos aos ensaios de controle de qualidade, sendo que a formulação 1 apresentou friabilidade superior a 1,5%, tornando esta formulação imprópria para a realização dos perfis de dissolução e continuidade dos estudos. Os comprimidos obtidos a partir das formulações F2 e F3 apresentaram resultados satisfatórios em relação aos ensaios de variação de peso, dureza, friabilidade, tempo de desintegração e doseamento do AMH. Estas duas formulações foram selecionadas para realização dos perfis de dissolução utilizando água e tampão acetato pH 4,5. Para ambos os meios avaliados, houve um aumento na quantidade dissolvida de AMH a partir dos comprimidos em relação ao AMH puro, demonstrando que os CI podem ser estratégias uteis no desenvolvimento farmacotécnico de novas formas farmacêuticas sólidas orais.Universidade Federal de Santa MariaBrasilFarmacologiaUFSMPrograma de Pós-Graduação em Ciências FarmacêuticasCentro de Ciências da SaúdeRolim, Clarice Madalena Buenohttp://lattes.cnpq.br/2270654658839508Adams, Andréa Inês Hornhttp://lattes.cnpq.br/6872246935204149Mortari, Sergio Robertohttp://lattes.cnpq.br/7784609477475171Cardoso, Simone Gonçalveshttp://lattes.cnpq.br/3679502590339850Teixeira, Helder Ferreirahttp://lattes.cnpq.br/6652867749152426Rubim, Alexandre Machado2019-08-19T12:22:12Z2019-08-19T12:22:12Z2016-12-02info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisapplication/pdfhttp://repositorio.ufsm.br/handle/1/17958porAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2022-06-01T11:38:00Zoai:repositorio.ufsm.br:1/17958Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2022-06-01T11:38Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.none.fl_str_mv Dispersões sólidas e complexos de inclusão como estratégia para o incremento da solubilidade de amiodarona
Solid dispersion and inclusion complex as strategy for the enhancement of amiodarone solubility
title Dispersões sólidas e complexos de inclusão como estratégia para o incremento da solubilidade de amiodarona
spellingShingle Dispersões sólidas e complexos de inclusão como estratégia para o incremento da solubilidade de amiodarona
Rubim, Alexandre Machado
Dispersão sólida
Complexo de inclusão
Comprimidos
Perfil de dissolução
Cloridrato de amiodarona
Solid dispersion
Inclusion complex
Tablets
Dissolution profile
Amiodarone hydrochloride
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
title_short Dispersões sólidas e complexos de inclusão como estratégia para o incremento da solubilidade de amiodarona
title_full Dispersões sólidas e complexos de inclusão como estratégia para o incremento da solubilidade de amiodarona
title_fullStr Dispersões sólidas e complexos de inclusão como estratégia para o incremento da solubilidade de amiodarona
title_full_unstemmed Dispersões sólidas e complexos de inclusão como estratégia para o incremento da solubilidade de amiodarona
title_sort Dispersões sólidas e complexos de inclusão como estratégia para o incremento da solubilidade de amiodarona
author Rubim, Alexandre Machado
author_facet Rubim, Alexandre Machado
author_role author
dc.contributor.none.fl_str_mv Rolim, Clarice Madalena Bueno
http://lattes.cnpq.br/2270654658839508
Adams, Andréa Inês Horn
http://lattes.cnpq.br/6872246935204149
Mortari, Sergio Roberto
http://lattes.cnpq.br/7784609477475171
Cardoso, Simone Gonçalves
http://lattes.cnpq.br/3679502590339850
Teixeira, Helder Ferreira
http://lattes.cnpq.br/6652867749152426
dc.contributor.author.fl_str_mv Rubim, Alexandre Machado
dc.subject.por.fl_str_mv Dispersão sólida
Complexo de inclusão
Comprimidos
Perfil de dissolução
Cloridrato de amiodarona
Solid dispersion
Inclusion complex
Tablets
Dissolution profile
Amiodarone hydrochloride
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
topic Dispersão sólida
Complexo de inclusão
Comprimidos
Perfil de dissolução
Cloridrato de amiodarona
Solid dispersion
Inclusion complex
Tablets
Dissolution profile
Amiodarone hydrochloride
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
description This study aimed to develop solid dispersions (SD) and inclusion complex (IC) using as carriers hydrophilic polymers (polyethylene glycol PEGs 1500, 4000 and 6000) and cyclodextrins (CDs) (β–cyclodextrin, metil-β-cyclodextrin and hydroxypropy-β-cyclodextrin), respectively, in order to verify the influence of each technological approach in the solubility of Amiodarone Hydrochloride (AMH). SD was prepared in the proportion AMH:PEGs of 1:1 and 1:10 (w/w) by the fusion and kneading techniques. IC were prepared by co-evaporation, freeze-drying and spray-drying methods, and the proportion AMD: CD of 1:1 (w/w) was used. For both approaches, AL-type solubility diagrams and thermodynamic approaches favorable to the formation of this new solid entity were obtained. The AMH solubility in different physiological media (acid buffer pH 1.2, acetate buffer pH 4.5 and phosphate buffer pH 6.8 and water) showed a strong dependence of its ionization due to the presence of amine chemical, which ionizes itself in a greater proportion in more acid means, below the AMH pKA (6.56). In order to characterize SD and CI, different techniques were used, such as X-Ray Diffraction (XRD), Forrier Transform Infrared Spectroscopy (FT-IR), Differential Scanning Calorimetry (DSC), Scanning Electronic Miscroscopy (SEM), Proton Nuclear Magnetic Resonance (RMN), determination of Specific Surface Area of the particles (SBET) and studies about Molecular Modeling (MM), as well as the determination of dissolution profiles between pure AMH and the solid products obtained. From the DRX, FT-IR and DSC analysis, it was possible to verify a strong interaction in a molecular level between AMH and the studied carriers. With the aid of SEM and SSA analysis, it was diagnosed a morphological alteration on the AMH crystals after the IC formation, as well as an increase of the superficial area of the particles in relation to pure AMH. For the determination of each portion of AMH molecule that is inside the cyclodextrin cavity, RMN and MM were used. RMN spectra showed strong evidence that the complexation process with methyl-β-cyclodextrin occurred by the lipophilic side, constituted by a diethylamide group. MM was used from an IC containing AMH and methyl-β-cyclodextrin in order to determine the binding energy, amount of charge transferred and the distances between the principal atoms. According to the results, it was determined a strong interaction between the diethylamide group of AMH with the methyl-β-cyclodextrin cavity, compounding a stable complex with the binding energy of 0.76 eV, confirming the results found by RMN. The obtained dissolution profiles showed to suffer a great influence of SD and CI, as well as the preparation methods of these products. It was also developed three formulations for the obtainment of immediate release tablets containing 10 mg de AMH complex with methyl-β-cyclodextrin by direct compression. The batches were submitted to tests of quality control, and the formulation 1 presented friability superior to 1.5%, which rendered this formulation improper for the execution of dissolution profiles and continuation of the studies. The tablets obtained from the F2 and F3 formulations presented satisfactory results in relation to the tests of variation of weigh, hardness, friability, disintegration time and AMH content. These two formulations were selected for the execution of dissolution profiles using water and acetate buffer pH 4.5. For both evaluated mediums, there was an increase in the dissolved amount of AMH from the tablets in relation to the pure AMH, demonstrating that IC can be useful strategies in the pharmacotechnical developments of new solid oral pharmaceutical ways.
publishDate 2016
dc.date.none.fl_str_mv 2016-12-02
2019-08-19T12:22:12Z
2019-08-19T12:22:12Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/17958
url http://repositorio.ufsm.br/handle/1/17958
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Farmacologia
UFSM
Programa de Pós-Graduação em Ciências Farmacêuticas
Centro de Ciências da Saúde
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Farmacologia
UFSM
Programa de Pós-Graduação em Ciências Farmacêuticas
Centro de Ciências da Saúde
dc.source.none.fl_str_mv reponame:Manancial - Repositório Digital da UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Manancial - Repositório Digital da UFSM
collection Manancial - Repositório Digital da UFSM
repository.name.fl_str_mv Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1805922036310081536